ChartRow logo
PeersKMBCHDSJMHRLCLEL
Share this page

CLX financial statements

The full income statement, balance sheet, and cash-flow statement for Clorox Company (The) (CLX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR −1.8%10Y CAGR +1.6%YoY +33.3%
$7.2B TTM$1.9B Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Gross profit

5Y CAGR −2.3%10Y CAGR +0.9%YoY +29.2%
$3B TTM$770M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Net income

5Y CAGR −3.7%10Y CAGR −1.0%YoY +112.5%
$677M TTM$170M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

EPS (diluted)

5Y CAGR −2.9%10Y CAGR −0.2%YoY +113.8%
$5.55 TTM$1.39 Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Operating cash flow

5Y CAGR −13.7%10Y CAGR −2.4%YoY +53.8%
$662M TTM$143M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Capital expenditure

5Y CAGR −9.0%10Y CAGR +1.9%YoY +5.6%
$209M TTM$38M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Free cash flow

5Y CAGR −15.6%10Y CAGR −3.9%YoY +84.2%
$453M TTM$105M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Shares (diluted)

5Y −4.1%10Y −7.3%YoY −0.8%
121.9M TTM122M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Dividend per share

5Y CAGR +2.0%10Y CAGR +4.8%YoY +0.8%
$4.98 TTM$2.50 Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Shares outstanding (point-in-time)

2024-09 123.8M2024-12 123.2M2025-03 123.3M2025-06 122.3M2025-09 122.0M2025-12 120.9M2026-03 120.9M2026-06 120.9M2026-09 121.1M-2.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
Revenue6.72B-5.4%7.10B+0.2%7.09B-4.0%7.39B+4.0%7.11B-3.2%
2.84B-11.5%3.21B+5.4%3.05B+4.8%2.91B+14.3%2.54B-20.4%
Cost of revenue3.88B-0.4%3.89B-3.8%4.04B-9.7%4.48B-1.8%4.56B+10.1%
Research & development116M-4.1%121M-4.0%126M-8.7%138M+4.5%132M-11.4%
Selling, general & administrative1.07B-5.2%1.12B-3.7%1.17B-1.4%1.18B+24.0%954M-5.0%
Restructuring—0.00-100.0%29.0M-59.2%71.0M—
Amortization of intangibles28.0M+33.3%21.0M-27.6%29.0M-3.3%30.0M-3.2%31.0M-3.1%
Interest expense130M+47.7%88.0M-2.2%90.0M+0.0%90.0M-15.1%106M+7.1%
Equity-method income3.00M-25.0%4.00M-20.0%5.00M+25.0%4.00M-33.3%6.00M+20.0%
Pre-tax income791M-26.6%1.08B+170.9%398M+67.2%238M-60.8%607M-32.6%
Income tax190M-25.2%254M+139.6%106M+37.7%77.0M-43.4%136M-24.9%
587M-27.5%810M+189.3%280M+87.9%149M-67.7%462M-34.9%
Net income to non-controlling interest14.0M+0.0%14.0M+16.7%12.0M+0.0%12.0M+33.3%9.00M+0.0%
Net income to common587M-27.5%810M+189.3%280M+87.9%149M-67.7%462M-34.9%
$4.81-26.2%$6.52+189.8%$2.25+87.5%$1.20-67.8%$3.73-33.2%
EPS (basic)$4.82-26.5%$6.56+190.3%$2.26+86.8%$1.21-67.7%$3.75-33.7%
Weighted-avg shares (basic)122M-1.4%124M-0.5%124M+0.5%124M+0.4%123M-2.0%
Weighted-avg shares (diluted)122M-1.7%124M-0.4%125M+0.5%124M+0.2%124M-2.7%
Dividends per share$4.96+1.6%$4.88+1.7%$4.80+1.7%$4.72+35.6%$3.48-22.5%
Balance Sheetas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
1.82B+13.4%1.61B-0.9%1.62B-11.3%1.83B+6.0%1.73B-5.7%
Cash & equivalents143M-14.4%167M-17.3%202M-45.0%367M+100.5%183M-42.6%
Accounts receivable791M-3.7%821M+18.1%695M+1.0%688M+1.0%681M+12.7%
Inventory777M+48.6%523M-17.9%637M-8.5%696M-7.8%755M+0.4%
Prepaid expenses113M+16.5%97.0M+10.2%88.0M+14.3%77.0M-27.4%106M-31.2%
7.79B+40.2%5.56B-3.3%5.75B-3.3%5.95B-3.5%6.16B-2.8%
Property, plant & equipment1.51B+19.3%1.27B-3.7%1.31B-2.2%1.34B+0.8%1.33B+2.5%
Operating lease right-of-use401M+20.4%333M-7.5%360M+4.0%346M+1.2%342M+3.0%
Goodwill1.95B+58.3%1.23B+0.1%1.23B-1.9%1.25B-19.6%1.56B-1.1%
Intangible assets—566M-16.9%681M-4.4%712M-19.5%884M-3.7%
Other non-current assets517M-7.3%558M+2.4%545M+18.0%462M+46.7%315M-16.7%
2.77B+44.5%1.92B+21.9%1.57B-17.9%1.92B+7.5%1.78B-13.2%
Accounts payable996M+18.9%838M-11.8%950M-7.0%1.02B+6.4%960M+3.2%
Accrued liabilities1.60B-12.5%1.83B+23.0%1.49B-10.4%1.66B+12.9%1.47B-12.3%
Short-term & current debt1.09B+27075.0%4.00M+0.0%4.00M-92.0%50.0M-78.9%237M-21.0%
Current lease liability86.0M-1.1%87.0M+3.6%84.0M-3.4%87.0M+11.5%78.0M-3.7%
Finance lease liability (current)16.0M+6.7%15.0M+15.4%13.0M+44.4%9.00M+50.0%6.00M+20.0%
7.54B+48.5%5.08B-3.4%5.26B-5.4%5.56B+2.4%5.43B-5.5%
Long-term debt3.98B+60.3%2.48B+0.1%2.48B+0.2%2.48B+0.1%2.47B-0.4%
Non-current lease liability366M+20.0%305M-8.7%334M+7.7%310M-1.3%314M+4.3%
Operating lease liability (total)452M+15.3%392M-6.2%418M+5.3%397M+1.3%392M+2.6%
Finance lease liability (total)78.0M+116.7%36.0M+5.9%34.0M+13.3%30.0M+57.9%19.0M-5.0%
Finance lease liability62.0M+195.2%21.0M+0.0%21.0M+0.0%21.0M+61.5%13.0M-13.3%
Deferred tax liabilities17.0M-15.0%20.0M-9.1%22.0M-21.4%28.0M-57.6%66.0M-1.5%
Other non-current liabilities405M+15.4%351M-58.6%848M+2.8%825M+4.3%791M-5.2%
90.0M-72.0%321M-2.1%328M+49.1%220M-60.4%556M+35.3%
Preferred stock0.000.000.000.000.00
Common stock131M+0.0%131M+0.0%131M+0.0%131M+0.0%131M+0.0%
Additional paid-in capital1.31B-0.5%1.32B+2.4%1.29B+3.5%1.25B+3.6%1.20B+1.3%
Retained earnings386M-10.6%432M+72.8%250M-57.1%583M-44.4%1.05B+1.2%
Treasury stock1.58B+12.7%1.40B+18.4%1.19B-4.8%1.25B-7.4%1.35B-3.6%
Accumulated other comprehensive income-157M+0.0%-157M-1.3%-155M+68.6%-493M-2.9%-479M+12.3%
Non-controlling interest162M+0.6%161M-1.8%164M-2.4%168M-2.9%173M-4.4%
Total equity incl. non-controlling252M-47.7%482M-2.0%492M+26.8%388M-46.8%729M+23.1%
Total liabilities & equity7.79B+40.2%5.56B-3.3%5.75B-3.3%5.95B-3.5%6.16B-2.8%
Common shares issued131M+0.0%131M+0.0%131M+0.0%131M+0.0%131M+0.0%
Common shares outstanding121M-1.4%123M-1.2%124M+0.3%124M+0.5%123M+0.3%
Shares outstanding (cover)121M-1.1%122M-1.3%124M+0.0%124M+0.5%123M+0.3%
Treasury shares9.82M+22.0%8.05M+23.1%6.54M-5.5%6.92M-8.8%7.59M-4.7%
Cash Flowas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
612M-37.6%981M+41.2%695M-40.0%1.16B+47.3%786M-38.4%
Depreciation & amortization247M+12.8%219M-6.8%235M-0.4%236M+5.4%224M+6.2%
Intangible amortization28.0M+33.3%21.0M-27.6%29.0M-3.3%30.0M-3.2%31.0M-3.1%
Share-based compensation48.0M-40.7%81.0M+9.5%74.0M+1.4%73.0M+40.4%52.0M+4.0%
Deferred income taxes81.0M+550.0%-18.0M+82.0%-100M+32.9%-149M-3080.0%5.00M+115.6%
Change in inventory71.0M+212.7%-63.0M-14.5%-55.0M+5.2%-58.0M-422.2%18.0M-93.6%
-2.30B-2347.9%-94.0M+46.3%-175M+21.5%-223M+2.6%-229M+49.3%
Capital expenditure207M-5.9%220M+3.8%212M-7.0%228M-9.2%251M-24.2%
Free cash flow405M-46.8%761M+57.6%483M-48.1%930M+73.8%535M-43.4%
Acquisitions2.10B0.000.000.000.00-100.0%
Other investing activities-10.0M-600.0%2.00M+110.0%-20.0M-300.0%-5.00M+77.3%-22.0M-161.1%
1.67B+280.5%-924M-41.1%-655M+13.0%-753M-9.3%-689M+50.5%
Long-term debt issued2.74B0.000.000.00-100.0%1.08B
Long-term debt repaid0.000.000.000.00-100.0%1.41B
Net short-term debt1.08B0.00+100.0%-45.0M+76.1%-188M-179.3%237M
Common stock repurchased256M-22.9%332M0.000.00-100.0%25.0M-97.2%
Dividends paid602M+0.0%602M+1.2%595M+2.1%583M+2.1%571M+2.3%
FX effect on cash-2.00M0.00+100.0%-26.0M0.00+100.0%-6.00M-150.0%
Net change in cash-23.0M+37.8%-37.0M+77.0%-161M-188.5%182M+231.9%-138M+75.1%
Interest paid122M+25.8%97.0M-4.9%102M+3.0%99.0M+11.2%89.0M+0.0%
Income taxes paid104M-60.6%264M-23.9%347M+375.3%73.0M-27.0%100M-67.0%
Valuation Ratiosas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
Market cap11.4B-22.8%14.7B-13.1%16.9B-13.9%19.7B+13.4%17.4B-21.4%
P/E19.4×+6.6%18.2×-74.2%70.6×-46.6%132.2×+251.7%37.6×+20.8%
P/S1.7×-18.4%2.1×-11.8%2.4×-11.8%2.7×+9.1%2.4×-18.8%
P/B126.4×+175.5%45.9×-75.4%186.2×+108.1%89.5×+186.6%31.2×-41.9%
P/FCF28.1×+45.1%19.4×-34.9%29.7×+40.4%21.2×-34.8%32.5×+38.8%
Earnings yield5.2%-6.2%5.5%+288.3%1.4%+87.2%0.76%-71.6%2.7%-17.2%
FCF yield3.6%-31.1%5.2%+53.6%3.4%-28.8%4.7%+53.3%3.1%-28.0%
Dividend yield5.3%+29.7%4.1%+15.6%3.5%+18.5%3.0%+20.2%2.5%-1.1%
Source filing10-K10-K10-K10-K10-K

About this data

Source: CLX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CLX filings on SEC EDGAR → Not investment advice.